Precision Medicine for Your Practice: Prenatal Cell-free DNA Screening-CNE

Precision Medicine for Your Practice: Prenatal Cell-free DNA Screening-CNE is organized by The Jackson Laboratory.

Release Date: August 22, 2019
Expiration Date: September 21, 2020

Target Audience:
This activity is designed to meet the educational needs of practicing advanced practice nurses, physicians and physician assistants who provide prenatal care.

Claiming Your Credit:
In order to claim credit
• Answer the pre-assessment questions
• Work through the module content in its entirety
• Successfully complete the post-assessment answering 3 out of 5 questions correctly and
• Complete the evaluation.
• Nurses are eligible for a maximum of .50 contact hours upon the completion of this activity

Description:
Prenatal providers and patients have more options than ever before for testing and screening for fetal aneuploidy, including cell-free DNA screening, also called noninvasive prenatal testing (NIPS or NIPT). While cell-free DNA screening is a powerful tool, it is not the best test for all pregnant women. The technology behind cell-free DNA screening enables high detection rates for Down syndrome and other chromosome conditions, but also confers specific benefits, limitations, and challenges in results interpretation and counseling.  Precision Medicine for Your Practice is a series of short (30 min), online modules covering specific topics in genomics and precision medicine. In this module, Prenatal Cell-free DNA Screening, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care for the purpose of facilitating patient decision-making. This online module will include five parts: overview information via an animated video; practice cases to facilitate learning-by-doing; and "dig deeper," logistics, and additional resources for those who are interested in more detail.

Objectives:
Upon completion of this educational activity, the participant will be able to:
• Determine whether cell-free DNA screening is appropriate for the patient.
• Interpret results of cell-free DNA screening in the context of the patient characteristics.

Additional details will be posted as soon as they are available.